Report Iran - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Nov 23, 2022

Iran - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Single report
Sent by email within 24h (Mon-Fri)

Iran: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Iran

In 2021, after nine years of growth, there was significant decline in the Iranian human and animal blood market, when its value decreased by -19.6% to $X. Over the period under review, consumption, however, enjoyed prominent growth. As a result, consumption attained the peak level of $X, and then contracted dramatically in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Iran

In value terms, human and animal blood production shrank notably to $X in 2021 estimated in export price. Overall, production, however, continues to indicate a significant increase. The most prominent rate of growth was recorded in 2020 with an increase of 56%. As a result, production reached the peak level of $X, and then contracted markedly in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Iran

In 2021, after four years of decline, there was significant growth in overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume increased by 11,596% to X tons. Over the period under review, exports showed significant growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood exports skyrocketed to $X in 2021. In general, exports saw a significant increase. The most prominent rate of growth was recorded in 2015 when exports increased by 1,077% against the previous year. The exports peaked at $X in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

Exports by Country

Slovenia (X tons) was the main destination for human and animal blood exports from Iran, with a approx. 97% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of volume to Slovenia stood at +853.2%.

In value terms, Slovenia ($X) also remains the key foreign market for human and animal blood exports from Iran.

From 2012 to 2021, the average annual rate of growth in terms of value to Slovenia stood at +364.7%.

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2021, with a decrease of -95.7% against the previous year. Over the period under review, the export price, however, saw a resilient increase. The growth pace was the most rapid in 2018 an increase of 211%. The export price peaked at $X per ton in 2020, and then fell remarkably in the following year.

As there is only one major export destination, the average price level is determined by prices for Slovenia.

From 2012 to 2021, the rate of growth in terms of prices for Switzerland amounted to +133.3% per year.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Iran

In 2021, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by 7.5% to X tons for the first time since 2018, thus ending a two-year declining trend. In general, imports continue to indicate buoyant growth. The pace of growth was the most pronounced in 2016 when imports increased by 167% against the previous year. Imports peaked at X tons in 2018; however, from 2019 to 2021, imports remained at a lower figure.

In value terms, human and animal blood imports skyrocketed to $X in 2021. Overall, imports showed a tangible increase. The growth pace was the most rapid in 2016 with an increase of 272% against the previous year. Imports peaked at $X in 2017; however, from 2018 to 2021, imports failed to regain momentum.

Imports by Country

In 2021, Turkey (X tons) constituted the largest supplier of human and animal blood to Iran, with a 45% share of total imports. Moreover, human and animal blood imports from Turkey exceeded the figures recorded by the second-largest supplier, Denmark (X tons), twofold. The third position in this ranking was taken by Switzerland (X tons), with a 13% share.

From 2012 to 2021, the average annual growth rate of volume from Turkey amounted to +54.3%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (+7.0% per year) and Switzerland (+15.1% per year).

In value terms, Denmark ($X), South Korea ($X) and Turkey ($X) appeared to be the largest human and animal blood suppliers to Iran, together comprising 74% of total imports.

Turkey, with a CAGR of +52.9%, saw the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, rising by 9% against the previous year. In general, the import price, however, showed a pronounced curtailment. The most prominent rate of growth was recorded in 2016 when the average import price increased by 39% against the previous year. Over the period under review, average import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.

Prices varied noticeably country of origin: the country with the highest price was South Korea ($X per ton), while the price for Switzerland ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by South Korea (+19.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the world?
+
The countries with the highest volumes of consumption in 2021 were the United States, China and India, together accounting for 51% of global consumption. These countries were followed by Canada, Japan, Russia, Brazil, France, Spain and the UK, which together accounted for a further 22%.
What are the largest producers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the world?
+
The country with the largest volume of human and animal blood production was the United States, comprising approx. 40% of total volume. Moreover, human and animal blood production in the United States exceeded the figures recorded by the second-largest producer, China, twofold. The third position in this ranking was taken by India, with a 6.9% share.
What are the leading suppliers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to Iran?
+
In value terms, the largest human and animal blood suppliers to Iran were Denmark, South Korea and Turkey, together comprising 74% of total imports.
What are the leading importers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses from Iran?
+
In value terms, Slovenia remains the key foreign market for human and animal blood exports from Iran.
What is the average export price for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Iran?
+
The average human and animal blood export price stood at $9,497 per ton in 2021, shrinking by -95.7% against the previous year.
What is the average import price for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Iran?
+
In 2021, the average human and animal blood import price amounted to $240,149 per ton, rising by 9% against the previous year.

This report provides an in-depth analysis of the market for human and animal blood in Iran. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
• Iran

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in Iran
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
REPORT DESCRIPTION
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption In 2007-2021
Table 5:
Imports, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Value Terms, By Country, 2012–2021
Table 7:
Import Prices, By Country Of Origin, 2012–2021
Table 8:
Exports, In Physical Terms, By Country, 2012–2021
Table 9:
Exports, In Value Terms, By Country, 2012–2021
Table 10:
Export Prices, By Country Of Destination, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2007-2021
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2007-2021
Figure 5:
Trade Balance, In Physical Terms, 2007-2021
Figure 6:
Trade Balance, In Value Terms, 2007-2021
Figure 7:
Per Capita Consumption, 2007-2021
Figure 8:
Market Forecast To 2030
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2012–2021
Figure 21:
Production, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, 2012–2021
Figure 23:
Imports, In Value Terms, 2012–2021
Figure 24:
Imports, In Physical Terms, By Country, 2021
Figure 25:
Imports, In Physical Terms, By Country, 2012–2021
Figure 26:
Imports, In Value Terms, By Country, 2012–2021
Figure 27:
Import Prices, By Country Of Origin, 2012–2021
Figure 28:
Exports, In Physical Terms, 2012–2021
Figure 29:
Exports, In Value Terms, 2012–2021
Figure 30:
Exports, In Physical Terms, By Country, 2021
Figure 31:
Exports, In Physical Terms, By Country, 2012–2021
Figure 32:
Exports, In Value Terms, By Country, 2012–2021
Figure 33:
Export Prices, By Country Of Destination, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET